Latest Technology & Life Sciences News from Mass High Tech
Intelligence for New England's Innovation economy
Mass High Tech Industry Directories
ANCHOR THERAPEUTICS INC
Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!
About:
Anchor Therapeutics is a venture-backed, pre-clinical stage company. We are developing first-in-class novel allosteric GPCR modulators, called pepducins, to address intractable targets in several therapeutic areas including cancer, inflammation, metabolism, heart disease and pain.
Headlines from Mass High Tech about ANCHOR THERAPEUTICS INC
Print this Listing
Product Information
| Industry Classification | Biopharma/Biotechnology |
| Primary Business Focus | Biotechnology - Pharmaceutical |
Details
| Year Established | 2007 |
| Ownership Type | Private |
| No. of Employees at this location | Subscriber access only |
| Total Number Employees | Subscriber access only |
| Foreign Distribution | Subscriber access only |
Contacts
| Thomas McMurry | Interim President/SVP Preclinical R&D | |||
| Stephen Hunt | CSO |
* Downloads will not contain Personnel E-mail addresses
Search the Directory
Company Overview
| Focus | Biotechnology - Pharmaceutical |
| Location | Cambridge, MA |
| Size | Subscriber access only |
| Website | http://www.anchortx.com |
| Revenue | Subscriber access only |
Contact Information
| Address | One Kendall Sq Bldg 200 Suite 2203 Cambridge, MA, 02139 |
| Phone | 617-715-1999 |
| Subscriber access only | |
| Website | www.anchortx.com |